Clinical Scorecard: Myopia: The Myth of Stabilization
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia |
| Key Mechanisms | Axial elongation is the primary structural factor associated with long-term visual morbidity. |
| Target Population | Children and adolescents with myopia. |
| Care Setting | Ophthalmology and optometry clinics. |
Key Highlights
- Refractive stability does not equate to cessation of axial elongation.
- Myopia progression can continue into the 20s and beyond.
- Treatment cessation based solely on refractive measurements can be misleading.
- Lifestyle modifications are essential for ongoing myopia management.
- Monitoring axial length trends is crucial for treatment decisions.
Guideline-Based Recommendations
Diagnosis
- Monitor both refraction and axial length for signs of myopia progression.
Management
- Consider tapering treatment rather than abrupt cessation.
- Educate families on the biology of myopia and the importance of ongoing vigilance.
Monitoring & Follow-up
- Track axial elongation trends over time, especially in late adolescence.
Risks
- Premature treatment cessation may lead to rebound phenomena and accelerated myopia progression.
Patient & Prescribing Data
Children and adolescents with myopia, particularly those at risk for progression.
Interventions include orthokeratology, atropine, and multifocal soft contact lenses.
Clinical Best Practices
- Reinforce lifestyle modifications such as outdoor breaks and reduced near work.
- Adopt a data-driven approach centered on axial stability and individual risk.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.